Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2019–2023 · research · R01
Dynamic Prediction of Renal Failure Using Longitudinal Prognostic Information among Patients with Chronic Kidney Disease and Kidney Transplant
Brad C Astor · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
Kelly K Hunt · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Prevention
Expanding Tobacco Use Cessation in Northeast Texas
Alexander Prokhorov · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2024 · research · R01
Anatomical Modeling to Improve the Precision of Image Guided Liver Ablation
Kristy Brock · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Building a Diverse Biomedical Workforce Through Communication Across Difference
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · research · R01
Genetic and Epigenetic Biomarkers for B-cell Lymphoma
Ken H. Young · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Targeting mitochondrial complex I in acute lymphoblastic leukemia
Marina Y Konopleva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
Chunru Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Therapeutic strategies against EGFR exon 20 mutant lung cancer
John V. Heymach · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi
Jonathan M Kurie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Statistical methods and tools for cancer risk prediction in families with germline mutations in TP53
Wenyi Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
Scott Kopetz · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2026 · research · R35
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
Scott E. Evans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting mitochondrial complex I in acute lymphoblastic leukemia
Marina Y Konopleva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Di Zhao · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2024 · cooperative agreement · U01
Patient-Derived Models of Prostate Cancer for Personalized Medicine
Yu Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · career development · K99
Determining the Immunological Consequences of DNA Replication Stress Response Defects in Renal Cells Carcinoma to Improve Immunotherapy Outcomes
Daniel James Mcgrail · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Dynamic Prediction of Renal Failure Using Longitudinal Prognostic Information among Patients with Chronic Kidney Disease and Kidney Transplant
Brad C Astor · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2021 · fellowship · F31
The Study of Immune Effects in Gliomas Treated with Oncolytic Viruses in Combination with IDO Inhibitors
Teresa T Nguyen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Academic Research
Targeting Hypomethylating Resistance in Myelodysplastic Syndromes
Simona Colla · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2021 · research · R25
Sexual and Gender Minority Cancer Curricular Advances for Research and Education (SGM Cancer CARE)
Shine Chang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
Michael Davies · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2023 · contract · N01
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
Powel Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
Kelly K Hunt · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2026 · research · R35
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
Scott E. Evans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Rigorous and reproducible mutational analysis of the urinary exosomal DNA
Colin P.N. Dinney · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
Cullen Mitsuo Taniguchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Academic Research
Recombinant Antibody Production Core (RAPC)at Science Park
Kevin Mcbride · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2026 · research · R35
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
Scott E. Evans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
Chunru Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Role of SETD5 in Chromatin Regulation and Tumorigenesis
Or P. Gozani · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing heterochromatin dysfunction as a driving alteration in cancer
Jason Huse · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
DELINEATING THE EVOLUTION AND ECOLOGY OF CHEMORESISTANCE IN BREAST CANCER WITH SINGLE CELL GENOMICS
Nicholas Navin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
Eduardo Vilar Sanchez · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · fellowship · F31
The Role of HIF2-Induced Wnt5a in Small Intestine Regeneration after Radiation Injury
Carolina Jannet Garcia Garcia · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing heterochromatin dysfunction as a driving alteration in cancer
Jason Huse · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · contract · N01
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
Powel Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Anatomical Modeling to Improve the Precision of Image Guided Liver Ablation
Kristy Brock · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
A Novel Hsp90 Inhibitor as a Chemo and Radiosensitizer in Adults with Glioblastoma
Vinay K Puduvalli · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
